A phase 3 randomised double-blind placebo-controlled trial of mirtazapine as a pharmacotherapy for methamphetamine use disorder: a study protocol for the Tina Trial

20246 citationsJournal Articlegold Open Access

Authors

Australian and New Zealand Clinical Trials Registry ACTRN12622000235707. Registered on February 9, 2022.

Good health and well-being

Published in: Trials

Volume 25, Issue 1, pp. 408-408

Field-Weighted Citation Impact: 2.29